Hyponatremia, a common electrolyte imbalance in older adults, results from physiological aging, medication use, and comorbidities, with significant implications for morbidity and quality of life. This narrative review aims to explore the impact of dietary habits and nutritional deficiencies on the development and management of hyponatremia in this population. A literature search identified relevant studies addressing the risk factors related to sodium balance, dietary intake, and nutrition. The key findings reveal that low sodium and age-related changes increase vulnerability to hyponatremia and its associated risks, including cognitive decline and falls. Nutritional strategies, such as optimizing sodium and protein intake and reducing processed food consumption, may offer preventative benefits. Future research should focus on tailored dietary interventions and establishing sodium intake guidelines specific to older adults. Implementing such strategies could improve the health outcomes and reduce the healthcare costs associated with hyponatremia in older populations.
Nivolumab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody and was the first immune checkpoint inhibitor drug approved for use in advanced non-small cell lung cancer (NSCLC). In this report, we describe a rare case of Lambert-Eaton myasthenic syndrome (LEMS), which developed as a side effect of nivolumab in a patient with metastatic lung squamous cell carcinoma. Our patient, who was previously treated with nivolumab for metastatic squamous cell carcinoma of the lung, appeared with a headache, swollen face, dysarthria, asthenia, xerostomia, and drooping eyelid. Early testing indicated no thymomas or newly developing tumors in whole-body scans, and the blood workup was normal. We came to the conclusion that nivolumab-induced LEMS was the cause of the symptoms after performing nerve conduction investigations ruling out other differentials. We believe our clinical experience of this rare and unexpected adverse event should be shared.
Hyponatremia, a common electrolyte imbalance in older adults, results from physiological aging, medication use, and comorbidities, with significant implications for morbidity and quality of life. This narrative review aims to explore the impact of dietary habits and nutritional deficiencies on the development and management of hyponatremia in this population. A literature search identified relevant studies addressing sodium balance, dietary intake, and nutrition related risk factors. Key findings reveal that low sodium and age-related changes, increase vulneratbility to hyponatremia and its associated risks, including cognitive decline and falls. Nutritional strategies, such as opti-mizing sodium and protein intake and reducing processed food consumption, may offer preven-tative benefits. Future research should focus on tailored dietary interventions and establishing so-dium intake guidelines specific to older adults. Implementing such strategies could improve health outcomes and reduce healthcare costs associated with hyponatremia in older populations.
An older woman with dementia and type 2 diabetes was started on semaglutide and subsequently developed severe psychological and physical symptoms, including apathy, significant weight loss and decreased appetite. These symptoms markedly improved after the medication was discontinued. This case underscores the importance of recognising potential psychiatric side effects of semaglutide, especially in older adults with cognitive impairment. The experience highlights the need for careful monitoring when prescribing semaglutide in this population and suggests that discontinuation should be considered if adverse symptoms arise. It also raises awareness about the limited safety data on semaglutide in older patients, emphasising the necessity of further research to understand its effects on this vulnerable group.